Literature DB >> 7737727

Measuring forearm blood flow and interpreting the responses to drugs and mediators.

N Benjamin1, A Calver, J Collier, B Robinson, P Vallance, D Webb.   

Abstract

Venous occlusion plethysmography has been widely used to study forearm blood flow. The principle of the technique is straightforward: the rate of swelling of the forearm during occlusion of venous return is used to assess the rate of arterial inflow. Provided that perfusion pressure (arterial blood pressure) remains constant, changes in flow reflect changes in smooth muscle tone in small arteries and arterioles. Local infusion into the brachial artery allows assessment of the direct effect of drugs on vascular tone and has been used to probe the roles of endogenous mediators. The technique is at its most powerful when dose-response relationships to different drugs or mediators within a single study are being compared but can also be used for comparison of responses to drugs between healthy control subjects and patient populations. However, when responses between groups are being compared, it is important to take into account the starting conditions of baseline blood flow and pressure. This article describes venous occlusion plethysmography, discusses the presentation and analysis of data (dose of drug or concentration? forearm blood flow or resistance?), and highlights certain potential problems and limitations of the technique as a means of studying disease states.

Entities:  

Mesh:

Year:  1995        PMID: 7737727     DOI: 10.1161/01.hyp.25.5.918

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  63 in total

1.  Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placement.

Authors:  H A Walker; G Jackson; J M Ritter; P J Chowienczyk
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 2.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

3.  Responses to endothelin-1 in patients with advanced cirrhosis before and after liver transplantation.

Authors:  A Helmy
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 4.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Systemic vascular endothelial cell dysfunction in normal pressure glaucoma.

Authors:  Christine Buckley; Patrick W F Hadoke; Emer Henry; Colm O'Brien
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

6.  Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.

Authors:  Neeraj Dhaun; Fiona E Strachan; David E Newby; Neil R Johnston; Neville F Ford; Janis L Hammett; Maria Palmisano; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

Review 7.  Nitric oxide in the human cardiovascular system--SKB lecture 1997.

Authors:  P Vallance
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

8.  Pain and changes in peripheral resistance at high vascular transmural pressure in the human forearm.

Authors:  N D C Green; M D Brown; J H Coote
Journal:  Eur J Appl Physiol       Date:  2007-05-03       Impact factor: 3.078

9.  Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men.

Authors:  James E Sharman; Prasad Gunaruwan; Wade L Knez; Matthias Schmitt; Susan A Marsh; Gary R Wilson; John R Cockcroft; Jeff S Coombes
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

10.  Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles.

Authors:  K Swaminathan; J Davies; J George; N S Rajendra; A D Morris; A D Struthers
Journal:  Diabetologia       Date:  2008-03-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.